China Life Insurance Company Limited (HK:2628) has announced impressive financial results for the year ending December 31, 2024, demonstrating robust performance across key metrics.
The company achieved record highs in several key performance indicators, including total assets, investment assets, and net profit. This strong financial performance reinforces China Life’s position as a leader in the insurance industry.
China Life maintained its industry-leading status with gross written premiums of RMB671,457 million. Furthermore, the company’s embedded value surpassed RMB1.4 trillion, signaling substantial growth and stability.
Beyond financial performance, China Life reinforced its commitment to supporting both national development and social security initiatives. The company made significant investments in the real economy and advanced its environmental, social, and governance (ESG) practices, ultimately earning a Grade A MSCI ESG rating, acknowledging its commitment to responsible business practices.
About China Life Insurance Company Limited
China Life Insurance Company Limited is a prominent provider of a variety of insurance products and services, specializing in life insurance, pension products, and annuities. The company holds a key position in China’s financial sector and is recognized for its leadership in market scale and overall value.
Key Financial Data
- YTD Price Performance: 9.46%
- Average Trading Volume: 11,612
- Technical Sentiment Signal: Sell
- Current Market Cap: $123.5B
For comprehensive information about 2628 stock, consult TipRanks’ Stock Analysis page.
